Cargando…

Epidemiology of human African trypanosomiasis

Human African trypanosomiasis (HAT), or sleeping sickness, is caused by Trypanosoma brucei gambiense, which is a chronic form of the disease present in western and central Africa, and by Trypanosoma brucei rhodesiense, which is an acute disease located in eastern and southern Africa. The rhodesiense...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Jose R, Simarro, Pere P, Diarra, Abdoulaye, Jannin, Jean G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130665/
https://www.ncbi.nlm.nih.gov/pubmed/25125985
http://dx.doi.org/10.2147/CLEP.S39728
_version_ 1782330362724089856
author Franco, Jose R
Simarro, Pere P
Diarra, Abdoulaye
Jannin, Jean G
author_facet Franco, Jose R
Simarro, Pere P
Diarra, Abdoulaye
Jannin, Jean G
author_sort Franco, Jose R
collection PubMed
description Human African trypanosomiasis (HAT), or sleeping sickness, is caused by Trypanosoma brucei gambiense, which is a chronic form of the disease present in western and central Africa, and by Trypanosoma brucei rhodesiense, which is an acute disease located in eastern and southern Africa. The rhodesiense form is a zoonosis, with the occasional infection of humans, but in the gambiense form, the human being is regarded as the main reservoir that plays a key role in the transmission cycle of the disease. The gambiense form currently assumes that 98% of the cases are declared; the Democratic Republic of the Congo is the most affected country, with more than 75% of the gambiense cases declared. The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci”, which are located in Sub-Saharan Africa, mainly in remote rural areas. The risk of contracting HAT is, therefore, determined by the possibility of contact of a human being with an infected tsetse fly. Epidemics of HAT were described at the beginning of the 20th century; intensive activities have been set up to confront the disease, and it was under control in the 1960s, with fewer than 5,000 cases reported in the whole continent. The disease resurged at the end of the 1990s, but renewed efforts from endemic countries, cooperation agencies, and nongovernmental organizations led by the World Health Organization succeeded to raise awareness and resources, while reinforcing national programs, reversing the trend of the cases reported, and bringing the disease under control again. In this context, sustainable elimination of the gambiense HAT, defined as the interruption of the transmission of the disease, was considered as a feasible target for 2030. Since rhodesiense HAT is a zoonosis, where the animal reservoir plays a key role, the interruption of the disease’s transmission is not deemed feasible.
format Online
Article
Text
id pubmed-4130665
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-41306652014-08-14 Epidemiology of human African trypanosomiasis Franco, Jose R Simarro, Pere P Diarra, Abdoulaye Jannin, Jean G Clin Epidemiol Review Human African trypanosomiasis (HAT), or sleeping sickness, is caused by Trypanosoma brucei gambiense, which is a chronic form of the disease present in western and central Africa, and by Trypanosoma brucei rhodesiense, which is an acute disease located in eastern and southern Africa. The rhodesiense form is a zoonosis, with the occasional infection of humans, but in the gambiense form, the human being is regarded as the main reservoir that plays a key role in the transmission cycle of the disease. The gambiense form currently assumes that 98% of the cases are declared; the Democratic Republic of the Congo is the most affected country, with more than 75% of the gambiense cases declared. The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci”, which are located in Sub-Saharan Africa, mainly in remote rural areas. The risk of contracting HAT is, therefore, determined by the possibility of contact of a human being with an infected tsetse fly. Epidemics of HAT were described at the beginning of the 20th century; intensive activities have been set up to confront the disease, and it was under control in the 1960s, with fewer than 5,000 cases reported in the whole continent. The disease resurged at the end of the 1990s, but renewed efforts from endemic countries, cooperation agencies, and nongovernmental organizations led by the World Health Organization succeeded to raise awareness and resources, while reinforcing national programs, reversing the trend of the cases reported, and bringing the disease under control again. In this context, sustainable elimination of the gambiense HAT, defined as the interruption of the transmission of the disease, was considered as a feasible target for 2030. Since rhodesiense HAT is a zoonosis, where the animal reservoir plays a key role, the interruption of the disease’s transmission is not deemed feasible. Dove Medical Press 2014-08-06 /pmc/articles/PMC4130665/ /pubmed/25125985 http://dx.doi.org/10.2147/CLEP.S39728 Text en © 2014 Franco et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Franco, Jose R
Simarro, Pere P
Diarra, Abdoulaye
Jannin, Jean G
Epidemiology of human African trypanosomiasis
title Epidemiology of human African trypanosomiasis
title_full Epidemiology of human African trypanosomiasis
title_fullStr Epidemiology of human African trypanosomiasis
title_full_unstemmed Epidemiology of human African trypanosomiasis
title_short Epidemiology of human African trypanosomiasis
title_sort epidemiology of human african trypanosomiasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130665/
https://www.ncbi.nlm.nih.gov/pubmed/25125985
http://dx.doi.org/10.2147/CLEP.S39728
work_keys_str_mv AT francojoser epidemiologyofhumanafricantrypanosomiasis
AT simarroperep epidemiologyofhumanafricantrypanosomiasis
AT diarraabdoulaye epidemiologyofhumanafricantrypanosomiasis
AT janninjeang epidemiologyofhumanafricantrypanosomiasis